U.S. Food and Drug Administration approves effective new tool to help smokers quit

PITTSBURGH, October 31, 2002 -- The nearly 50 million smokers now have an effective new treatment to help them quit. The U.S. Food and Drug Administration (FDA) today approved the CommitTM Lozenge -- the first and only nicotine lozenge -- for over-the-counter (OTC) sale. The Commit Lozenge, from the marketers of Nicorette, helps control cravings by delivering craving-fighting medicine fast. Additionally, its groundbreaking new dosage-selection tool, "Time to First Cigarette" (TTFC), enables smokers to get the right strength of nicotine based on how quickly they need to smoke after waking.

The Commit Lozenge has been shown to be effective in helping people quit, including smokers who have tried quitting before. The benefits of the Commit Lozenge were even greater when quitters used the minimum recommended number of lozenges per day in the early part of their quit attempts (i.e., nine lozenges per day for the first six weeks of therapy).

"As the marketers of Nicorette nicotine gum and NicoDerm CQ nicotine patch, we have provided increased access to safe and effective tools that have helped millions of smokers quit successfully," said Steve Burton, vice president of Smoking Control, Strategic Development and Switch at GlaxoSmithKline Consumer Healthcare. "We understand, however, that when trying to quit, smokers have different needs. Our newest option, the Commit Lozenge, provides smokers with a new treatment option to help them manage their quit attempts while also offering a unique dosage-selection tool to ensure that they are receiving the right amount of medicine."

The Commit Lozenge Features Unique Dosage Selection Tool: "Time to First Cigarette"

The Commit Lozenge uses a unique method for smokers to determine their degree of physical dependence on nicotine. This groundbreaking new indicator is called Time To First Cigarette (TTFC) and is available only with the Commit Lozenge. With TTFC, those who smoke the

Contact: Kristin Zajaczkowski
Porter Novelli

Page: 1 2 3

Related medicine news :

1. ENBREL application for early, active rheumatoid arthritis filed with the U.S. Food and Drug Administration
2. Fact Sheet -- Rectal Administration Of Diazepam For Acute Repetitive Seizures (RADARS) Study
3. Study Questions Common Practice Of Steroid Administration To Induce Lung Development In Premature Infants
4. FDA approves Pfizers Lyrica for the treatment of the two most common forms of neuropathic pain
5. FDA approves Enablex for treatment of overactive bladder
6. FDA approves Fosrenol(R) in end-stage renal disease (ESRD) patients
7. FDA approves Adderall XR (R) to treat ADHD in adults
8. FDA approves EPZICOM
9. FDA approves new labelling for Seroquel in bioplar mania
10. FDA approves Enbrel to treat psoriasis
11. FDA approves Climara Pro to treat menopause symptoms

Post Your Comments:

(Date:9/1/2020)... , ... September 01, 2020 , ... Feeding Matters ... for children with Pediatric Feeding Disorder (PFD), is pleased to announce that the U.S. ... stand-alone diagnostic code (R code) in the next edition of the U.S. International ...
(Date:8/31/2020)... , ... August 31, 2020 , ... ... non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma ... – today announced the 10th Anniversary of Blood Cancer Awareness Month (BCAM) and ...
(Date:8/31/2020)... ... August 31, 2020 , ... ... solution for chiropractors, announced today the launch of its integrated, HIPAA compliant, telehealth ... running their virtual practice in under 90 seconds. , According to the ...
(Date:8/31/2020)... ... ... Cure for Covid-19 “PTS” with Mediation & Hypnosis , At this very turbulent time ... experiencing deep anxiety, immense stress, and right now are needing serious relief from a constant ... the planet are experiencing a great degree of emotional discomfort, be it fear or worrying ...
(Date:8/29/2020)... ... August 29, 2020 , ... When professor and author Randy Pausch was ... most people would. Rather than become melancholic, however, he put together a final lecture ... dreams. Randy Pausch took a negative situation and turned it into something that inspired ...
Breaking Medicine News(10 mins):
(Date:8/28/2020)... ... August 28, 2020 , ... ... aesthetic beauty, bringing a unique perspective and approach. Armed with her qualifications from ... out to share her knowledge of the human body with the nation and ...
(Date:8/27/2020)... ... August 27, 2020 , ... Bleep LLC, maker of the ... apnea patient, is the company’s new spokesperson. , “In my line of work, a ... I found the Bleep DreamPort it was a Bleeping no brainer for me,” said ...
(Date:8/26/2020)... (PRWEB) , ... August 26, 2020 , ... ... How Chiropractic Care Helps Sports Injuries. The infographic breaks down ways that chiropractors ... quicker, healthier recovery. , According to ScripHessco “Athletes have an unusual amount of ...
Breaking Medicine Technology:
Cached News: